Cargando…

Co-production of randomized clinical trials with patients: a case study in autologous hematopoietic stem cell transplant for patients with scleroderma

BACKGROUND: Increasingly, it is argued that clinical trials struggle to recruit participants because they do not respond to key questions or study treatments that patients will be willing or able to use. This study explores how elicitation of patient-preferences can help designers of randomized cont...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aguiar, Magda, Laba, Tracey-Lea, Munro, Sarah, Burch, Tiasha, Beckett, Jennifer, Kaal, K. Julia, Bansback, Nick, Hudson, Marie, Harrison, Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428135/ https://www.ncbi.nlm.nih.gov/pubmed/34503552 http://dx.doi.org/10.1186/s13063-021-05575-0

Ejemplares similares

The financial burden of accessing care for people with scleroderma in Canada: a patient-oriented, cross-sectional survey
por: Trenaman, Logan, et al.
Publicado: (2023)

Understanding multidisciplinary care for people with rheumatic disease in British Columbia, Canada, through patients, nurses and physicians voices: a qualitative policy evaluation
por: Apantaku, Glory, et al.
Publicado: (2021)

Patient perspectives on the British Columbia Biosimilars Initiative: a qualitative descriptive study
por: Chew, Caitlin, et al.
Publicado: (2021)

Review: Hematopoietic Stem Cell Transplantation for Scleroderma: Effective Immunomodulatory Therapy for Patients With Pulmonary Involvement
por: Sullivan, Keith M., et al.
Publicado: (2016)

The impact of the Choosing Wisely Canada campaign on the simultaneous use of angiotensin-converting-enzyme inhibitors and angiotensin receptor blockers: interrupted time-series analysis
por: Laba, Tracey-Lea, et al.
Publicado: (2022)

Autologous Fat Grafting in the Treatment of Facial Scleroderma
por: Gheisari, Mehdi, et al.
Publicado: (2018)

Do patients and health care providers have discordant preferences about which aspects of treatments matter most? Evidence from a systematic review of discrete choice experiments
por: Harrison, Mark, et al.
Publicado: (2017)

Mobilization Strategies in Myeloma Patients Intended for Autologous Hematopoietic Cell Transplantation
por: Jantunen, Esa, et al.
Publicado: (2023)

Using Discrete Choice Experiment to elicit patient preferences for osteoporosis drug treatments: where to from here?
por: Laba, Tracey-Lea
Publicado: (2014)

Outcomes of Salvage Autologous Versus Allogeneic Hematopoietic Cell Transplantation for Relapsed Multiple Myeloma After Initial Autologous Hematopoietic Cell Transplantation
por: Wirk, Baldeep, et al.
Publicado: (2013)

Implantation of autologous fat globules in localized scleroderma and idiopathic lipoatrophy - report of five patients
por: Zanelato, Tiago Pina, et al.
Publicado: (2013)

Therapeutic effects of autologous hematopoietic stem cell transplantation in multiple myeloma patients
por: FU, CHENGCHENG, et al.
Publicado: (2013)

Physiological problems in patients undergoing autologous and allogeneic hematopoietic stem cell transplantation
por: Kapucu, Sevgisun, et al.
Publicado: (2014)

Sleep Disruption Among Cancer Patients Following Autologous Hematopoietic Cell Transplantation
por: Nelson, Ashley M., et al.
Publicado: (2017)

Autologous Hematopoietic Stem Cell Transplantation for Patients with Lymphoma-Associated Hemophagocytic lymphohistiocytosis
por: Song, Yue, et al.
Publicado: (2021)

Autologous hematopoietic transplantation following COVID‐19 infection
por: Brzycki, Marthilde, et al.
Publicado: (2021)

Analysis of Factors that Influence Hematopoietic Recovery in Autologous Transplanted Patients with Hematopoietic Stem Cells from Peripheral Blood
por: Grubovic, Rada M., et al.
Publicado: (2017)

Safety profile of autologous hematopoietic stem cell mobilization and transplantation in patients with systemic sclerosis
por: Helbig, Grzegorz, et al.
Publicado: (2017)

Prevalence and Significance of Sarcopenia in Multiple Myeloma Patients Undergoing Autologous Hematopoietic Cell Transplantation
por: Williams, Alexis, et al.
Publicado: (2020)

Tandem Autologous Hematopoietic Stem Cell Transplantation in Very Young Patients with Multiple Myeloma
por: Naithani, Rahul, et al.
Publicado: (2020)

Total Facial Autologous Fat Grafting for Treating Skin Manifestations in Scleroderma
por: Berl, Ariel, et al.
Publicado: (2022)

Endocrinopathies after Allogeneic and Autologous Transplantation of Hematopoietic Stem Cells
por: Orio, Francesco, et al.
Publicado: (2014)

Autologous hematopoietic stem cell transplantation in classical Hodgkin's lymphoma
por: Cortez, Afonso José Pereira, et al.
Publicado: (2011)

SECOND MALIGNANCIES AFTER AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION IN CHILDREN
por: Danner-Koptik, Karina E, et al.
Publicado: (2012)

SHIPi Enhances Autologous and Allogeneic Hematopoietic Stem Cell Transplantation
por: Fernandes, Sandra, et al.
Publicado: (2015)

Herpes zoster after autologous hematopoietic stem cell transplantation
por: Santos, Kelli Borges dos, et al.
Publicado: (2016)

Autologous Hematopoietic Stem Cell Transplantation for Treatment of Systemic Sclerosis
por: Del Papa, Nicoletta, et al.
Publicado: (2018)

Optimizing autologous hematopoietic stem cell transplantation for acute leukemia
por: Pang, Aiming, et al.
Publicado: (2021)

Scleroderma with Nodular Scleroderma
por: Srisuttiyakorn, Chutika, et al.
Publicado: (2016)

Cardiovascular risk and use of conicity index in patients submitted to autologous hematopoietic stem cell transplantation
por: de Morais, Suelyne Rodrigues, et al.
Publicado: (2018)

Immunological Adverse Events After Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis Patients
por: Strunz, Patrick-Pascal, et al.
Publicado: (2021)

Membranous Glomerulopathy After Autologous Hematopoietic Stem Cell Transplant in a Patient With Multiple Myeloma
por: Rodríguez Feria, Daniela, et al.
Publicado: (2021)

Real-world application of autologous hematopoietic stem cell transplantation in 507 patients with multiple sclerosis
por: Burt, Richard K., et al.
Publicado: (2021)

COVID-19 in the context of autologous hematopoietic stem cell transplantation for a patient with autoimmune disease
por: Alsuliman, Tamim, et al.
Publicado: (2022)

Autologous hematopoietic stem cell transplantation promotes connective tissue remodeling in systemic sclerosis patients
por: Zanin-Silva, Djúlio C., et al.
Publicado: (2022)

Pediatric Autologous Hematopoietic Stem Cell Transplantation: Safety, Efficacy, and Patient Outcomes. Literature Review
por: Testi, Anna Maria, et al.
Publicado: (2023)

Resetting the T Cell Compartment in Autoimmune Diseases With Autologous Hematopoietic Stem Cell Transplantation: An Update
por: Lutter, Lisanne, et al.
Publicado: (2018)

Sequential, Autologous Hematopoietic Stem Cell Transplant Followed by Renal Transplant in Multiple Myeloma
por: Bhowmik, D., et al.
Publicado: (2017)

Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma without Cryopreservation
por: Al-Anazi, Khalid Ahmed
Publicado: (2012)

Peripheral hematopoietic progenitor cell mobilization for autologous transplantation in hematologic malignancies
por: Marques Jr, José Francisco Comenalli
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_kbu11fhdhhh54d1ag23i0mlv24